abstract |
The invention relates to compounds of general formula (I), to new substituted derivatives of diazepinoindole of general formula (I) and their pharmaceutically acceptable salts, as well as to pharmaceutical compositions containing such compounds, to their new intermediates, and also to the use of such compounds in treating or preventing disorders related to the activity of receptor 1 of melanin-concentrating hormone. |